Conformis's ROE % for the quarter that ended in Jun. 2023 was -135.80%. Conformis's PB Ratio for the quarter that ended in Jun. 2023 was 0.54.
Conformis's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -251.48%.
Conformis ROE % Adjusted to Book Value Historical Data
The historical data trend for Conformis's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Conformis's ROE % Adjusted to Book Value
For the Medical Devices subindustry, Conformis's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conformis's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conformis's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Conformis's ROE % Adjusted to Book Value falls into.
Conformis ROE % Adjusted to Book Value Calculation
Conformis's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Conformis ROE % Adjusted to Book Value Related Terms
Thank you for viewing the detailed overview of Conformis's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CFMS has been successfully added to your 